在心血管高风险患者中PCSK9抑制剂的应用价值:元分析
Liming Zhao1, Ying Liu2, Ziting Cao1
1Department of Vascular Surgery, Liu Zhou People's Hospital, Guangxi, 545006, China.
Iranian journal of public health
|July 24, 2023
概括
在高风险患者中,蛋白转化酶亚提利辛/凯辛9型 (PCSK9) 抑制剂有效降低脂质,减少主要心血管不良事件 (MACE). 虽然它们通常是安全的,但它们对死亡率的影响需要进一步调查.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 蛋白转化酶亚提利辛/凯辛9型 (PCSK9) 抑制剂是强大的降脂剂.
- 这些药物为心血管疾病 (CVD) 患者提供了改善的预后.
研究的目的:
- 系统地分析PCSK9抑制剂的安全性和有效性.
- 在已发表的随机对照试验 (RCT) 中评估PCSK9抑制剂.
主要方法:
- 在PubMed,EMBASE,MEDLINE,Cochrane图书馆和科学网上进行系统的搜索.
- 11项随机对照试验的元分析,涉及52511名参与者.
主要成果:
- PCSK9抑制剂显著降低了主要不良心血管事件 (MACE) 的风险 (OR=0.89,P=0.0009).
- 没有显著减少心血管死亡 (OR=0.95,P=0.38) 或所有原因死亡 (OR=0.93,P=0.18).
- 没有治疗出现不良事件 (TEAE) 的风险增加 (OR=0.98,P=0.28).
结论:
- PCSK9抑制剂在高风险心血管患者中显著降低MACE.
- PCSK9 抑制剂的耐受性很好.
- PCSK9抑制剂对死亡风险的影响尚不清楚.
相关概念视频
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
42
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
42
Coronary Artery Disease IV: Preventive Measures
25
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
25
Coronary Artery Disease V: Interprofessional Care
10
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
10
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.9K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.9K
Coronary Artery Disease I: Introduction
23
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
23
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
567
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
567


